Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: Serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial

Kiyoshi Hibi(Yokohama City University Medical Center), Masunori Matsuzaki(Ube (Japan)), Yukio Ozaki(Kyushu University), Hiroyuki Daida(Juntendo University Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Takeshi Kimura(Municipal Hirakata City Hospital), Masakazu Yamagishi, Katsumi Miyauchi(Tokyo Metropolitan Geriatric Hospital), Satoshi Saito(Nihon University), Takafumi Hiro(Nihon University), Tetsu Yamaguchi, Kazuo Kimura(Yokohama City University Medical Center)
Atherosclerosis
August 23, 2011
10.1016/j.atherosclerosis.2011.08.024
Cited by 25

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507